Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers
1.INSERM, EMI0227 Centre de Recherche en Cancérologie,CRLC Val d'Aurelle-Paul Lamarque,Cedex 5 Montpellier,France;2.CNRS UMR 5160,Montpellier,France;3.Abgenix, Inc,Fremont,USA
Abstract:
Background
Human monoclonal antibodies (MAbs) are needed for colon cancer radioimmunotherapy (RIT) to allow for repeated injections. Carcinoembryonic antigen (CEA) being the reference antigen for immunotargeting of these tumors, we developed human anti-CEA MAbs.